Leishmaniasis is a neglected public health problem caused by the protozoan species
belonging to the genus Leishmania affecting mostly the poor populations of developing …

Introduction: Parasitic diseases that pose a threat to human life include leishmaniasis–
caused by protozoan parasite Leishmania species. Existing drugs have limitations due to …

Endemic in 149 tropical and subtropical countries, neglected tropical diseases (NTDs) affect
more than 1 billion people annually with over 500,000 deaths. Among the NTDs, some of the …

Leishmaniasis is a major public health problem, and the alarming spread of parasite
resistance has increased the importance of discovering new therapeutic products. The …

The present study aimed to evaluate the antileishmanial effect, the mechanisms of action
and the association with miltefosine of Vernonia brasiliana essential oil against Leishmania …

Leishmaniasis is a vector-borne protozoan disease caused by an intracellular parasite
which globally affects 350 million people. This infectious disease mainly affects …

Studies in rural communities are important to maintain popular knowledge between
generations, as well as to identify new species for pharmaceutical production. Thus, the …

New therapeutics are urgently needed to treat visceral leishmaniasis (VL). Due to the fact
that drug discovery is a long and expensive process, the development of delivery systems to …

Background: Neglected tropical diseases (NTDs) like zoonotic cutaneous leishmaniasis
(ZCL), is a widespread infectious disease with high mortality and morbidity. Various …

The present study aimed to investigate the in vitro antileishmanial activity of
strychnobiflavone flavonoid against Leishmania infantum, as well as its mechanism of …